Home
This site is intended for healthcare professionals
MedAll Oncology
MedAll Oncology
Matt Teeney
Desilyn Alana
Anna Pogodina
Mohamed Aamer
Sue Gibson
Stephen McDonough
Mussab Mohammed Osman
David Ajuong A Chan
Mohamed Idris
Isikeli Litidamu
Noble Appah
Mohammad Flefil
Perla Villanueva
Ghada Abdelrafee
Team MedAll
Kavinda Perera
Aghabius Zakhary
Matt Teeney
Desilyn Alana
Anna Pogodina
Mohamed Aamer
Sue Gibson
Stephen McDonough
Mussab Mohammed Osman
David Ajuong A Chan
Mohamed Idris
Isikeli Litidamu
Noble Appah
Mohammad Flefil
211 followers
Featured
MedAll Editor
MedAll Editor
MedAll Editor
THREAD

Case Discussion: Advanced Prostate Cancer: Communication

Posted by MedAll Editor, 3 Jul 2024, 7 comments

Case Discussion: Advanced Prostate Cancer: Communication

Can you answer the questions about this case? Watch Prof Gain's session, who chairs a discussion on this topic in our Advanced Prostate Cancer Course

Mr. Taylor is a 79-year-old retired chef with a history of chronic kidney disease, congestive heart failure, and COPD. He recently presented to his primary care physician with new-onset back pain and urinary difficulties. Examination revealed mid-back tenderness and a diffusely enlarged prostate. His PSA level was markedly elevated at 65.4 ng/mL.

This program is funded by an independent grant from Merck. This online education program has been designed solely for healthcare professionals in USA. The content is not available for healthcare professionals in any other region.

Posted by MedAll Editor, 3 Jul 2024, 7 comments

MedAll Editor
MedAll Editor
MedAll Editor
THREAD

Case Discussion: Advanced Prostate Cancer: early (oligo) metastatic disease

Posted by MedAll Editor, 3 Jul 2024, 5 comments

Case Discussion: Advanced Prostate Cancer: early (oligo) metastatic disease

Can you answer the questions about this case? Watch Prof Gain's session, who chairs a discussion on this topic in our Advanced Prostate Cancer Course

Mr. Smith, a 65-year-old retired teacher in good overall health, presented for his annual checkup. His routine blood work revealed an increasing trend in his prostate-specific antigen (PSA) levels over the past two years. After experiencing increased urinary frequency and nocturia, he was referred to a urologist. An MRI revealed a lesion in the left posterior peripheral zone of the prostate with suspected extraprostatic extension. A subsequent MRI fusion biopsy confirmed high-risk prostate cancer (Grade Group 4). A PSMA-PET scan further revealed an avid lymph node and sclerotic bone metastasis, indicating early (oligo) metastatic disease.

This program is funded by an independent grant from Merck. This online education program has been designed solely for healthcare professionals in USA. The content is not available for healthcare professionals in any other region.

Posted by MedAll Editor, 3 Jul 2024, 5 comments

THREAD

You are invited too!

Posted by Sue Gibson, 22 Feb 2024, 1 comments

You are invited too!

MedAll Oncology has been created to encourage community for all those on MedAll with an interest in Oncology. Please feel free to create your own thread to chat with others.Maybe you have come across some interesting documentation you want to share, maybe you are doing some research and looking for colleagues.

Lets see what we can do with threads!

By following MedAll Oncology you will be kept up to date on all the comings and goings within this group!

We love to chat and hope you do too!

Posted by Sue Gibson, 22 Feb 2024, 1 comments

THREAD

Q&A for Sarcoma Insights - Diagnosis to Management | Georgina Wood

Posted by Sue Gibson, 21 Feb 2024, 3 comments

Q&A for Sarcoma Insights - Diagnosis to Management | Georgina Wood

Enhance your understanding of sarcoma by attending the insightful webinar titled, "Sarcoma Insights: Diagnosis to Management”, led by Dr. Georgina Wood. This session focuses on sarcoma's epidemiology, diagnosis and the latest treatment principles. Suitable for healthcare professionals, this learning activity is an opportunity to enrich your knowledge about sarcoma and improve patient outcomes in this specialized field. It's also important to note that the faculty and planners for this event do not have any financial ties to ineligible healthcare product companies.

Posted by Sue Gibson, 21 Feb 2024, 3 comments

Sue Gibson
Sue Gibson
Sue Gibson
THREAD

Suggestions for learning

Posted by Sue Gibson, 12 Feb 2024, 0 comments

Suggestions for learning

We are always looking for ideas about how we can help our community to develop in their professional careers while advancing the quality of patient care we can provide collectively. Please take a moment to let us know what topics you think we should cover.

Posted by Sue Gibson, 12 Feb 2024, 0 comments

Sue Gibson
Sue Gibson
Sue Gibson
THREAD

Welcome & introductions

Posted by Sue Gibson, 12 Feb 2024, 1 comments

Welcome & introductions

Welcome to MedAll Oncology. Why not take some time to introduce yourself, let us know what you do, where you come from and what your healthcare interests are.

Posted by Sue Gibson, 12 Feb 2024, 1 comments